<DOC>
	<DOCNO>NCT02528006</DOCNO>
	<brief_summary>For adductor spasmodic dysphonia , need establish new therapy present circumstance standard therapy establish yet exist therapy fail provide permanent effect . Evaluation efficacy type 2 thyroplasty use titanium bridge expand therapeutic option available adductor spasmodic dysphonia establishment standard therapy .</brief_summary>
	<brief_title>Treatment Adductor Spasmodic Dysphonia Type 2 Thyroplasty Using Titanium Bridges</brief_title>
	<detailed_description>Spasmodic dysphonia type functional dysphonia associate organic abnormality palsy larynx . The speech disorder disease cause involuntary intermittent spasm intralaryngeal muscle ( Castelon , 2002 ) . There curative treatment disease . Conservative therapy include voice training ( voice therapy ) muscle relaxant medication ease tension larynx speech , although much evidence support effectiveness either . An internationally employ therapy local injection botulinum toxin A intralaryngeal muscle suppress involuntary movement vocal cord . The injection administer percutaneously anterior neck within short time , number report indicate great 90 % efficacy treatment ( Tisch 2003 , Blitzer 2010 ) . However , local injection therapy effective limited period 3 4 month , periodic injection continue throughout life maintain relief symptom present circumstance . Type 2 thyroplasty operative procedure thyroid cartilage incise midline , incise gap open fix thyroarytenoid muscle attach side , vocal cord shut tightly speech even strong adduction glottis , symptom adductor spasmodic dysphonia cause excessive closure glottis due strong involuntary intermittent adduction intralaryngeal muscle ( Isshiki 2001 ) . In 2002 , titanium bridge make biocompatible pure titanium develop Japan exclusive use type 2 thyroplasty ( Isshiki 2004 ) . When titanium bridge use actual case , symptom disappear without recurrence operation ( Sanuki 2007 , Sanuki 2009 , Isshiki &amp; Sanuki 2009 , Sanuki 2010 ) . There need establish new therapy present circumstance standard therapy establish yet exist therapy fail provide permanent effect . Evaluation efficacy type 2 thyroplasty use titanium bridge expand therapeutic option available adductor spasmodic dysphonia establishment standard therapy .</detailed_description>
	<mesh_term>Dysphonia</mesh_term>
	<mesh_term>Hoarseness</mesh_term>
	<criteria>1 . Diagnosis adductor spasmodic dysphonia board certify otorhinolaryngologist certified OtoRhinoLaryngological Society Japan , Inc. 2 . At least 1 year experience subjective objective labor speech production , pause certain sound , due adductor spasmodic dysphonia 3 . A total score 20 Voice Handicap Index10 ( VHI10 ) 4 . Nonresponders voice therapy perform informed consent 5 . 18 80 year age inclusive time inform consent 6 . Written inform consent participate study , provide patient legally acceptable representative 1 . Dysphagia , laryngeal paralysis , structural disorder vocal cord 2 . Previous surgery adductor spasmodic dysphonia 3 . Local injection botulinum toxin type A intralaryngeal muscle within 6 month inform consent 4 . Serious concomitant diseases 5 . Surgery general anesthesia schedule study period surgery perform within past 4 week 6 . Participation study use intervention within 12 week informed consent , plan participation study study period enrollment study 7 . Psychiatric disorder require treatment , mental intellectual disability may affect conduct study 8 . A history alcoholism drug abuse 9 . A history hypersensitivity pure titanium 10 . Women pregnant plan become pregnant study period 11 . Patients deem ineligible study investigator reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Spasmodic Dysphonia</keyword>
	<keyword>Type 2 Thyroplasty</keyword>
	<keyword>Titanium Bridges</keyword>
	<keyword>Operation</keyword>
</DOC>